Invesco
ENZ

Invesco’s Enzo Biochem, Inc. ENZ Stock Holding History

Invesco’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-59,239
Closed -$190K – 4121
2021
Q4 		$190K Sell
59,239
-3,839
-6% -$13.1K ﹤0.01% 3791
2021
Q3 		$223K Buy
63,078
+2,209
+4% +$7.37K ﹤0.01% 3765
2021
Q2 		$193K Sell
60,869
-11,690
-16% -$36.8K ﹤0.01% 3797
2021
Q1 		$249K Sell
72,559
-6,961
-9% -$21.6K ﹤0.01% 3620
2020
Q4 		$200K Buy
79,520
+5,512
+7% +$12K ﹤0.01% 3534
2020
Q3 		$156K Sell
74,008
-1,872
-2% -$4.45K ﹤0.01% 3515
2020
Q2 		$170K Buy
75,880
+3,229
+4% +$8.3K ﹤0.01% 3514
2020
Q1 		$184K Buy
72,651
+11,781
+19% +$28.9K ﹤0.01% 3427
2019
Q4 		$160K Buy
60,870
+1,892
+3% +$5.65K ﹤0.01% 3558
2019
Q3 		$212K Sell
58,978
-589
-1% -$2.08K ﹤0.01% 3536
2019
Q2 		$201K Sell
59,567
-2,057
-3% -$7.25K ﹤0.01% 3613
2019
Q1 		$168K Buy
61,624
+50,276
+443% +$165K ﹤0.01% 3646
2018
Q4 		$32K Buy
11,348
+95
+0.8% +$311 ﹤0.01% 3732
2018
Q3 		$46K Sell
11,253
-1,569
-12% -$7.13K ﹤0.01% 3822
2018
Q2 		$67K Buy
+12,822
New +$78.1K ﹤0.01% 3792
2018
Q1 		– Sell
-111,063
Closed -$905K – 3778
2017
Q4 		$905K Sell
111,063
-41,913
-27% -$400K ﹤0.01% 3061
2017
Q3 		$1.6M Buy
152,976
+8,249
+6% +$91.6K ﹤0.01% 2729
2017
Q2 		$1.6M Sell
144,727
-38,732
-21% -$361K ﹤0.01% 2729
2017
Q1 		$1.54M Buy
183,459
+138,576
+309% +$976K ﹤0.01% 2782
2016
Q4 		$312K Sell
44,883
-86,338
-66% -$551K ﹤0.01% 3445
2016
Q3 		$668K Buy
+131,221
New +$784K ﹤0.01% 3141
2015
Q2 		– Sell
-9,300
Closed -$27K – 4375
2015
Q1 		$27K Sell
9,300
-1,810
-16% -$5.93K ﹤0.01% 3921
2014
Q4 		$49K Sell
11,110
-5,230
-32% -$24.9K ﹤0.01% 3915
2014
Q3 		$84K Buy
+16,340
New +$87.2K ﹤0.01% 3883

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Invesco's ENZ Position: Q1 2022 in Review

Invesco sold out of Enzo Biochem, Inc. (ENZ) in Q1 2022, closing a stake of 59,239 shares — an estimated $190K sold.

Invesco first reported a position in ENZ in Q3 2014 and held it in 24 quarters. The position peaked at $1.6M in Q3 2017. 51 funds tracked by Wall St. Rank hold ENZ as of Q1 2022.

  • Invesco reported no remaining Enzo Biochem, Inc. position as of Q1 2022 after selling out during the quarter.
  • Invesco sold 59,239 Enzo Biochem, Inc. shares in Q1 2022, an estimated $190K.
  • Invesco first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 24 quarters.
  • Invesco's Enzo Biochem, Inc. position peaked at $1.6M in Q3 2017.
  • 51 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2022.

Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.